Decreased phenytoin level after carboplatin treatment.
Dofferhoff
A S
AS
Berendsen
H H
HH
vd Naalt
J
J
Haaxma-Reiche
H
H
Smit
E F
EF
Postmus
P E
PE
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy*; D016190:Carboplatin; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D010672:Phenytoin / Q000097:blood*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D010672:Phenytoin; D016190:Carboplatin